Literature DB >> 12169818

Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy.

Carlos G V Murta1, Antônio F Moron, Márcio A P Avila, Carl P Weiner.   

Abstract

OBJECTIVE: To test the hypothesis the application of ductus venosus Doppler velocimetry may serve as a screening tool between 10 and 14 weeks' gestation for the detection of fetuses with chromosomal abnormalities.
METHODS: 372 consecutive fetuses were studied. Based on prior study, a chromosomal abnormality was suspected when either the nuchal translucency was above the 95th centile, or there was reversed or absent flow in the ductus venosus during atrial contraction. Sensitivity, specificity, and the negative and positive predictive values were calculated.
RESULTS: There were 29 chromosomally abnormal fetuses. Of these 29 fetuses, ductus venosus blood flow during atrial contraction was either absent (n = 2) or reversed (n = 25) in 93.1%. In the chromosomally normal fetuses (n = 343), only 6 (1.7%) had abnormal Doppler profiles in the ductus venosus (specificity = 98.3%, positive and negative predictive values = 81.8% and 99.4%, respectively).
CONCLUSION: The Doppler waveform of the ductus venosus was at least equal to NT thickness measurement for the detection of chromosomal abnormalities. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12169818     DOI: 10.1159/000063185

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  10 in total

1.  Human fetal cardiac function during the first trimester of pregnancy.

Authors:  K Mäkikallio; P Jouppila; J Räsänen
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 2.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

4.  Can the ductus venosus doppler predict the hemoglobinopathies?

Authors:  Atilla Karateke; Dilek Benk Silfeler; Arif Güngören; Raziye Keskin Kurt; Ayşe Güler Okyay; Recep Dokuyucu; Turker Ulutas; Burak Un; Hacer Paksoy; Ali Ulvi Hakverdi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 5.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

6.  The assessment of nuchal translucency and serum markers for down syndrome screening with ductus venosus Doppler measurements in the first trimester.

Authors:  Ozlem Ozer; Cenk N Sayın; Füsun G Varol
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-12-01

7.  Employ ductus venous blood flow in the early detection of trisomy 21, trisomy 18, and trisomy 13: A meta-analysis.

Authors:  Yibing Ge; Lili Xia; Yun Wu; Hongbao Cao
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

8.  Missed Down Syndrome Cases after First Trimester False-Negative Screening-Lessons to be Learned.

Authors:  Anca Angela Simionescu; Ana Maria Alexandra Stanescu
Journal:  Medicina (Kaunas)       Date:  2020-04-23       Impact factor: 2.430

Review 9.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 10.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.